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Background: Application of transcranial random noise stimulation (tRNS) between 0.1
and 640Hz of the primary motor cortex (M1) for 10min induces a persistent excitability
increase lasting for at least 60min. However, the mechanism of tRNS-induced cortical
excitability alterations is not yet fully understood.
Objective: The main aim of this study was to get first efficacy data with regard to the
possible neuronal effect of tRNS.
Methods: Single-pulse transcranial magnetic stimulation (TMS) was used to measure
levels of cortical excitability before and after combined application of tRNS at an intensity
of 1mA for 10min stimulation duration and a pharmacological agent (or sham) on eight
healthy male participants.
Results: The sodium channel blocker carbamazepine showed a tendency toward
inhibiting MEPs 5–60min poststimulation. The GABAA agonist lorazepam suppressed
tRNS-induced cortical excitability increases at 0–20 and 60min time points.
The partial NMDA receptor agonist D-cycloserine, the NMDA receptor antagonist
dextromethorphan and the D2/D3 receptor agonist ropinirole had no significant effects
on the excitability increases seen with tRNS.
Conclusions: In contrast to transcranial direct current stimulation (tDCS), aftereffects
of tRNS are seem to be not NMDA receptor dependent and can be suppressed by
benzodiazepines suggesting that tDCS and tRNS depend upon different mechanisms.
Keywords: transcranial random noise stimulation (tRNS), transcranial magnetic stimulation (TMS), transcranial
direct current stimulation (tDCS), lorazepam (LOR: GABAA receptor agonist), ropinirole (ROP: D2/D3 receptor
agonist), carbamazepine (CBZ: sodium channel blocker), dextromethorphan (DMO: NMDA receptor antagonist),
D-cycloserine (D-CYC: partial NMDA receptor agonist)
Introduction
Experience dependent neuronal activity changes lead to a strengthening or weakening of synap-
tic connections, summarized as neuroplasticity (Bliss and Lomo, 1973; Cooke and Bliss, 2006).
Transcranial stimulation by either magnetic (transcranial magnetic stimulation: TMS) or electrical
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methods (transcranial electrical stimulation: tES) allow for the
induction of similar neuroplastic alterations. In human subjects
the motor cortex (M1) is a preferred model for studying these
effects since the muscle twitch elicited by suprathreshold TMS
(motor-evoked-potential: MEP) allows for an easy readout of
plasticity alterations by using the MEP amplitude as a biomarker
(for a review see: Ziemann et al., 2008).
Transcranial direct current stimulation (tDCS) modulates
cortical excitability in a polarity, stimulation intensity and dura-
tion dependent way (Nitsche and Paulus, 2000; Batsikadze et al.,
2013; Monte-Silva et al., 2013); generally, it was observed anodal
stimulation increasing and cathodal stimulation decreasing lev-
els of motor cortical excitability (Nitsche and Paulus, 2000, 2001).
This dependency can be strongly modulated by co-application of
neuroactive drugs (Liebetanz et al., 2002; Nitsche et al., 2003a;
Abbruzzese et al., 2010), e.g., as seen with the dose-dependent
reversal of tDCS aftereffects by dopamine (Kuo et al., 2008;
Nitsche et al., 2009; Monte-Silva et al., 2010). Transcranial ran-
dom noise stimulation (tRNS) is a new tES method, which was
also shown to induce an increase in sustained levels of cortical
excitability in the M1 (Terney et al., 2008; Moliadze et al., 2010,
2012; Chaieb et al., 2011). Stimulation with 1mA tRNS leads to
a persistent elevation of single-pulse TMS elicited MEPs lasting
up to 1 h post-stimulation after 10min tRNS duration. Lower
intensities at around 0.4mA tRNS lead to inhibitory aftereffects
comparable to what has been observed with cathodal stimulation
(Moliadze et al., 2012).
With regard to the possible underlying mechanisms of these
neuroplastic effects it was shown that the electric field generated
by tDCS is able to increase or reduce the membrane potential
of neurons in a linear way, even in cell types with a spheri-
cal dendritic arborization pattern (Radman et al., 2009). With
invasive electrodes it has been shown that cellular targets closest
to the anode hyperpolarise, while those elements closest to the
cathode simultaneously depolarise (Chan et al., 1988). However,
the cellular targets of transcranially applied electrical currents
include morphologically and functionally distinct networks of
interneurons and pyramidal cell neurons (Radman et al., 2009).
Animal studies and in vitro slice preparation studies have demon-
strated that neurons with a non-symmetric dendriticmorphology
are more likely to be activated by the presence of an applied
electric field and that they are more susceptible to the polar-
ity of electric fields (Hern et al., 1962; Chan et al., 1988; Rad-
man et al., 2009). Pharmacological intervention in combination
with tDCS has revealed its NMDA receptor dependency (Liebe-
tanz et al., 2002) and further demonstrated the possibility of
selectively prolonging anodal aftereffects by applying the indirect
NMDA receptor agonist d-cycloserine, as well as amphetamine,
and modulating cathodal aftereffects by low dose pergolide, a
dopamine receptor agonist (Nitsche et al., 2004a,b, 2006; Monte-
Silva et al., 2009). Both carbamazepine, a voltage-gated sodium
channel blocker and flunarizine, a calcium channel antago-
nist, abolished the short-duration aftereffects induced by anodal
tDCS, but not by cathodal tDCS (Liebetanz et al., 2002; Nitsche
et al., 2003b). This suggests that the mechanisms underlying
tDCS are ion-channel dependent, selectively affecting neurons
and generating inhibitory and excitatory modulations in cortical
excitability, producing, respectively long-term depression (LTD)
and long-term potentiation (LTP)-like effects. Here, we have
implemented this combined approach for tRNS in order to gain a
better understanding of its underlying mechanisms. This experi-
ment was planned as a pilot study providing first efficacy data.We
administered five pharmacological agents in order to characterize
essential receptors and ion channels possibly involved in the gen-
eration of tRNS aftereffects: lorazepam (LOR: GABAA receptor
agonist), ropinirol (ROP: dopamine receptor 2/3 agonist), carba-
mazepine (CBZ: a sodium channel blocker), dextromethorphan
(DMO: NMDA receptor antagonist) and D-cycloserine (D-CYC:
partial NMDA receptor agonist).
Methods
Subjects
Eight healthy male subjects (mean age 30.1 ± 5.2 years) partici-
pated in the study. In order to estimate the numbers of subjects
needed, power analysis were done based on the results of previ-
ously published data (Liebetanz et al., 2002; Huang et al., 2007).
In order to detect the difference in the mean MEP size between
PLC + tES and a given drug condition + tES with 95% confi-
dence and 80% power, min. Seven subjects should be included.
All participants were informed as to all aspects of the experi-
ments and gave written consent. None of the participants suffered
from any neurological or psychological disorders, nor had any
metal implants or implanted devices, took any relevant medica-
tion regularly or prior to their participation. Seven of the sub-
jects were right-handed according to the Edinburgh handedness
inventory (Oldfield, 1971). All aspects of the protocol conformed
to the Declaration of Helsinki and were approved by the Ethics
Committee of theMedical Faculty of the University of Göttingen.
Transcranial Random Noise Stimulation
tRNS was delivered by a battery-driven electrical stimulator (Ver-
sion DC-Stimulator-Plus, NeuroConn GmbH, Ilmenau, Ger-
many) through conductive-rubber electrodes, placed in two
saline-soaked sponges. In the stimulationmode “noise” a random
level of current is generated for every sample (sampling rate 1280
samples per second). The random frequencies are normally dis-
tributed; the probability density function follows a bell-shaped
curve. In the frequency spectrum all coefficients have a similar
size (“white noise”). The noise signal contains all frequencies up
to half of the sampling rate, i.e., a maximum of 640Hz (Terney
et al., 2008). Due to the statistical characteristics the signal has no
DC offset, provided that the offset is set to zero.
The stimulation electrode was placed over the left M1, which
was determined prior to stimulation by single-pulse TMS (see
below). The return electrode was placed over the contralateral
orbit. The size of the stimulation electrode was 4× 4 cm and the
return electrode was 6 × 14 cm. The electrodes were fixated to
the head using elastic bands. tRNS was applied for 10min with a
current strength of 1mA.
Measuring Corticospinal Excitability
To detect current-driven changes of excitability, motor evoked
potentials (MEPs) of the right abductor digiti minimi muscle
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(ADM) were recorded following stimulation of its motor-cortical
representation field by single-pulse TMS. MEPs were induced
using a Magstim 200 magnetic stimulator (Magstim Company,
Whiteland, Wales, UK) with a figure-of-eight standard double
magnetic coil (diameter of one winding, 70mm; peak magnetic
field, 2.2 T; average inductance, 16.35µH). Surface electromyo-
gram (EMG) was recorded from the right ADM through a pair
of Ag-AgCl surface electrodes in a belly-tendon montage. Raw
signals were amplified, band-pass filtered (2Hz–3 kHz; sampling
rate, 5 kHz), digitized with a micro 1401 AD converter (Cam-
bridge Electronic Design, Cambridge, UK) controlled by Signal
Software (Cambridge Electronic Design, version 2.13), and stored
on a personal computer for oﬄine analysis. Complete relaxation
was controlled through visual feedback of EMG activity and
whenever it was necessary, the subject was instructed to relax.
The coil was held tangentially to the skull, with the handle point-
ing backwards and laterally at 45◦ from the midline, resulting in
a posterior-anterior direction of current flow in the brain. This
orientation of the induced electrical field is thought to be optimal
for stimulating the pyramidal tract neurons in the wall of the M1;
the representation of the newmotor cortex according to Rathelot
and Strick, from layers 6 through to layer 1 (Rathelot and Strick,
2009). The optimum position (hot-spot) was defined as the site
where TMS resulted consistently in the largest MEP in the rest-
ingmuscle. The site and the coil position weremarked with a skin
marker on the scalp to ensure that the coil was held in the correct
location throughout the experiment.
Pharmacological Interventions
Two hours prior to the beginning of the experimental session,
and two and half hours prior to the administration of tRNS,
subjects were given either: 100mg D-cycloserine (D-CYC), 2mg
ropinirol (ROP), 1mg lorazepam (LOR), 75mg dextromethor-
phan (DMO), 300mg carbamazepine (CBZ) or an equivalent
placebo agent (PLC). These types of drugs and their dosages
were previously tested in different tDCS studies (Liebetanz et al.,
2002; Nitsche et al., 2003b) and were found to have a maxi-
mum blood peak level around 2–3 h. All pharmacological agents
were orally administered. To avoid cumulative drug effects, all
experimental sessions were separated by a 2 week interval. Both
the subjects and the experimenter were blinded to the respective
pharmacological condition.
Experimental Procedure
The subjects received the combination of tRNS and a given drug
in a randomized order. The randomization was done by the coor-
dinating investigator, who had no contact to the subjects. They
were seated in a comfortable reclining chair with a mounted
headrest throughout the experiments. All experimental sessions
were conducted by the same investigator. Resting motor thresh-
old (RMT), active motor threshold (AMT), the intensity to evoke
MEP of ∼ 1mV peak-to-peak amplitude and a baseline of TMS-
evokedMEPs (40 stimuli) were recorded at 0.25Hz prior to stim-
ulation. Stimulus intensities (in percentage ofmaximal stimulator
output) of TMS were determined at the beginning of each exper-
iment. RMT was defined as the minimal output of the stimulator
that induced a reliable MEP (∼50µV in amplitude) in at least
three of six consecutive trials when the ADM muscle was com-
pletely relaxed. AMT was defined as the lowest stimulus intensity
at which three of six consecutive stimuli elicited reliable MEP
(∼200µV in amplitude) in the tonically contracting ADM mus-
cle of participants (contracting at half-maximal contraction of the
ADM) (Rothwell et al., 1999). Immediately following stimulation,
40 single test-pulse MEPs were recorded at 0.25Hz, i.e., approxi-
mately 0, 5, 10min post tRNS and then every 10min up to 60min;
then at 90, 120, 240min intervals and finally 24 h post tRNS.
Calculations and Statistics
Any MEPs with EMG artifacts were rejected. MEP amplitude
(peak-to-peak) was automatically calculated using the NuCursor
programme (IoN, UCL, London, UK) and the mean value (from
minimum 35 MEPs) was determined for each timepoint.
The main aim of this study was to get first efficacy data with
regard to the possible neuronal effect of tRNS. Therefore, Two-
Way repeated measures ANOVAs (DRUG (CBZ, LOR, DMO,
D-CYC, ROP) + tRNS vs. tRNS + PLC) × TIME (baseline, 0, 5,
10, 20, 30, 40, 50, 60, 90, 120, min and 24 h post-stimulation) were
used to compare a given different drug condition to the tRNS +
PLC condition; DRUG and TIME serving as independent vari-
ables, while MEP amplitude was the dependent variable. Effects
were considered significant if p ≤ 0.05. In the case of a signifi-
cant main effect of DRUG and interaction of TIME and DRUG, a
Fischer post-hoc test was performed. Student’s t-test was used to
compare baseline raw MEP amplitudes before stimulation with
those afterwards within the placebo condition. All data are given
as means± SEM.
Results
None of the participants reported any side effects of the tRNS
and/or medication. Among the baseline MEP values there were
no significant differences (ps > 0.8).
Placebo Drug Condition
As in previous experiments (Terney et al., 2008; Chaieb et al.,
2009; Moliadze et al., 2012) tRNS caused an elevation in MEP
sizes for 90min following 10min of stimulation (df = 7, t =
2.9–4.65, p < 0.05), with a tendency at 0min (p = 0.07) and
30–40min (p = 0.11 and 0.09) that might be due to the lower
number of subjects measured in this study.
Drug Interactions
Results of repeated measures ANOVAs conducted for main
effects and interactions with a given DRUG and DRUG × TIME
indicate that ROP, DMO, and D-CYC (Figures 2, 3, 5) had no
significant effect on TMS elicited MEP amplitudes, when com-
pared to the tRNS + PLC condition (Table 1), although DMO
showed a light tendency to inhibit MEPs compared to PLC
post-stimulation.
With regard to the application of CBZ, there was a signifi-
cant main effects of DRUG + tRNS condition [F(1,14) = 4.98;
p = 0.007] and factor TIME [F(10,14) = 2.09; p = 0.03].
CBZ showed a tendency toward inhibiting MEPs between 5–60
and 120min poststimulation (p < 0.05) (Figure 1). The effect
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FIGURE 1 | Shows the effect of CBZ on tRNS-induced aftereffects as measured by averaging TMS-evoked-MEPS from the M1 across 24h time
course. MEP values at each timepoint are averaged. Error bars indicate SEM. Asterisks indicate significant differences.
FIGURE 2 | Shows the effect of D-CYC on tRNS-induced aftereffects as measured by averaging TMS-evoked-MEPS from the M1 across 24h time
course. MEP values at each timepoint are averaged. Error bars indicate SEM.
Frontiers in Neuroscience | www.frontiersin.org 4 April 2015 | Volume 9 | Article 125
Chaieb et al. Carbamazepine and lorazepam modifies the after-effect of tRNS
FIGURE 3 | Shows the effect of DMO on tRNS-induced aftereffects as measured by averaging TMS-evoked-MEPS from the M1 across 24h time
course. MEP values at each timepoint are averaged. Error bars indicate SEM.
FIGURE 4 | Shows the effect of LOR on tRNS-induced aftereffects as measured by averaging TMS-evoked-MEPS from the M1 across 24h time
course. MEP values at each timepoint are averaged. Error bars indicate SEM. Asterisks indicate significant differences.
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FIGURE 5 | Shows the effect of ROP on tRNS-induced aftereffects as measured by averaging TMS-evoked-MEPS from the M1 across 24h time
course. MEP values at each timepoint are averaged. Error bars indicate SEM.
TABLE 1 | Results of the statistical analyses (repeated measures of
ANOVA) of each pharmacological condition on the effect of average MEP
size after stimulation of the M1 with tRNS compared with tRNS + PLC.
DRUG (1,14) TIME (10,14) DRUG ×
TIME (10,14)
F p F p F p
CBZ 4.98 0.007* 2.09 0.03* 1.56 0.11
LOR 3.3 0.09 1.67 0.08 1.85 0.05*
DMO 0.91 0.36 2.88 0.002* 0.47 0.9
D-CYC 2.1 0.17 2.22 0.06 0.87 0.56
ROP 0.7 0.41 3.00 0.001* 0.77 0.66
The table reports the F and p-values for conditions DRUG and TIME and for the interaction
between DRUG × TIME. Asterisks-bold italic values indicate significant results.
LOR on MEPs was significant for the interaction of DRUG ×
TIME [F(10,14) = 1.85; p = 0.05] (Figure 4). The post-hoc test
demonstrated significant differences at 0–20 (p < 0.01) and
60min time points (p < 0.05) between the tRNS + PLC and
tRNS+ LOR conditions.
Discussion
By using a combination of CNS active drugs in conjunction with
single-pulse TMS we were able to partially profile the recep-
tor mechanisms underlying tRNS-induced neuroplasticity. We
tested the involvement of GABAA (LOR) and D2/D3 receptors
(ROP) in addition to NMDA receptor blockade or potentia-
tion (DMO and D-CYC). Sodium channel conductivity was also
investigated with the application of CBZ. Results indicate that
tRNS induced plasticity is probably NMDA receptor indepen-
dent, as administration of DMO showed no blocking effect on
tRNS-induced excitability increases, although a light tendency
toward inhibition was seen. D-CYC, a partial NMDA recep-
tor agonist also showed no effect on tRNS aftereffects, in con-
trast to the expected prolongation of aftereffects (Nitsche et al.,
2004a). The main result of this study is that CBZ, a voltage gated
sodium channel blocker, significantly curtailed the excitabil-
ity enhancing effect of tRNS, normally lasting up to 60min.
Furthermore, administration of LOR showed a trend toward
reducing the increase in cortical excitability seen after applica-
tion of tRNS, which was most marked at the 0–20 and 60min
post-stimulation.
Our data also suggests no role of dopaminergic modulation
for tRNS, as ROP in a dosage of 2mg did not have an effect
on tRNS-induced aftereffects. In a comparable tDCS study ROP
produced a biphasic response, where low (0.125 and 0.25mg)
and high (1.0mg) dosages impaired both cathodal and anodal
tDCS-induced neuroplasticity, compared with the placebo condi-
tion (Monte-Silva et al., 2009). Under medium dosage (0.5mg),
ROP did not influence the anodal tDCS-elicited aftereffects. In
contrast, a prolonged inhibition was observed in the cathodal
tDCS condition. ROP in a dosage of 2mg was not tested in
this study. In another study low dose pergolide didn’t affect
anodally-induced MEP increases either; only the duration of
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cathodal excitability diminutions was clearly prolonged (Nitsche
et al., 2006). This result does not, however, exclude an influ-
ence of the dopaminergic system, since the interaction between
either L-Dopa or dopamine agonists and transcranial stimula-
tion is dose-dependent and complex (overview in Nitsche et al.,
2010).
The mechanisms underlying the inductive excitatory
aftereffects of tRNS are as yet unknown, and have been postu-
lated to be modulated through the potentiation of voltage- gated
sodium channels (Terney et al., 2008). The application of tRNS, a
repetitive subthreshold electrical stimulation applied to the intact
cortex, may alter the activation of voltage-gated sodium channels
(Bromm, 1968). A continual influx and eﬄux of ions across the
neuronal membrane has a high likelihood of being influenced by
random AC current. Repeated depolarization may, for example,
generate a cumulative cyclic response of sodium channels to
continually repolarise and depolarise, and in this fashion may
produce a heightened effect of the tRNS, resulting in the classical
increases in cortical excitability observed in studies reporting
tRNS-induced neuroplastic effects in the M1 (Terney et al., 2008;
Chaieb et al., 2009). The temporal summation of these weak
depolarising currents at the neuronal level may in turn, enhance
the communication between neurons firing at the same rate
and so may contribute to LTP-like changes, resulting in e.g., an
enhancement in cognitive performance at the behavioral level
(Fertonani et al., 2011; Cappelletti et al., 2013; Miniussi et al.,
2013; Snowball et al., 2013). Similar responses to repetitive high
frequency stimulation have also been observed in rodent electro-
physiological preparations, where a weak depolarization of the
neuronal membrane in cultured rat neurons could be observed
after the application of extracellular stimulation (Schoen and
Fromherz, 2008). The observation in this study that tRNS
aftereffects were reduced by administration of CBZ, a sodium
channel antagonist, suggests that tRNS-induced plasticity effects
may be indeed sodium channel dependent. The “leaky” nature of
sodium channels at subthreshold conductances, due to the ability
of sodium channels to rapidly recover from inactivation during
depolarization, means that a resurgent current upon repolar-
ization is present in some neuronal populations (Raman and
Bean, 1997; Grieco et al., 2005). This may be of importance since
sodium channels are one of the most abundant voltage-gated
ion channels present on the cell membrane (Yu and Catterall,
2003). The interaction between the membrane-modulating
effects of electrical currents and CBZ has also been investigated
using tDCS. CBZ administration resulted in the abolishment
of anodal stimulation induced increase in cortical excitation
but did not have any blocking effect upon cathodally induced
excitability decreases (Liebetanz et al., 2002; Nitsche et al.,
2003a).
In addition to the blocking effect of CBZ, LOR, a GABAA
receptor agonist, also influenced the amplitude of TMS-evoked-
MEPs after tRNS. The reduction in MEP amplitude started
immediately post-stimulation (0min) to 20min. This short
effect may be attributed to the relatively small dosage of LOR
administered to the participants. It may well be that at higher
dosages (2mg, instead of the 1mg administered here), LOR may
have a more pronounced effect of tRNS-induced aftereffects,
although at much higher doses unwanted side effects are also
exacerbated (Izaute and Bacon, 2005). We do not know yet to
what extent tRNS is affecting or influencing cortical rhythmic-
ity, which on a macroscopic level would be an amplification of
its more direct effects on the potentiation of ion channels at the
membrane. Even though the effect of LOR on tRNS-induced neu-
roplastic aftereffects was not significant, we were still able to see a
tendency toward a reduction of tRNS aftereffects.
As a result of the medication, none of the subjects complained
of dizziness, vertigo or fatigue. None of the experiments had to be
terminated due to side effects. Therefore, the blinding of subjects
or the person conducting the experiments was completely valid
during these measurements.
One of the limitations of this work is the small number of sub-
jects. The negative or small results might be related to the number
of subjects (n = 8), although the sample size calculations based
on previous results suggested that this number of subjects should
be sufficient. Indeed, previous studies recruited even less sub-
jects testing the effect of transcranial stimulation methods using
the same or similar drugs (e.g., Huang et al., 2007). Increasing
the sample size might result in more weighty changes (e.g., the
main effect of TIME was significant by several drugs, neverthe-
less the DRUG × TIME interaction was not). Nevertheless, this
study was designed as a pilot study providing first efficacy data. It
should be noted that these results apply only to the dosages used,
and to the parameters tested in this study. Further experiments
should also control the level of attention that can be substantially
altered by drugs (e.g., LOR) and might also affect tRNS-induced
plasticity.
Conclusion
Although most neuroplasticity induction mechanisms of tES
methods are thought to be mediated by NMDA-receptor poten-
tiation, this was not the case for our study (for a review on tES
see Paulus, 2011). We observed a more pronounced effect of
voltage-gated sodium channels on tRNS aftereffects. However,
the neuroplasticity-inducing effects of oscillating currents may lie
within the modulation of ion channels located on the neuronal
membrane, but may also affect ongoing cortical rhythmicity as
observed on the behavioral level (Fertonani et al., 2011). It may
appear that even though tRNS is subject to membrane modula-
tion effects, its potential role in interfering with ongoing cortical
rhythmicity is not mutually exclusive.
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